SPDR S&P Biotech ETF $XBI Stock Sold by Whalen Wealth Management Inc.

Whalen Wealth Management Inc. lowered its stake in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 67.3% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 3,610 shares of the exchange traded fund’s stock after selling 7,439 shares during the quarter. Whalen Wealth Management Inc.’s holdings in SPDR S&P Biotech ETF were worth $569,000 at the end of the most recent quarter.

Other hedge funds have also modified their holdings of the company. Wealth Management Partners LLC purchased a new position in shares of SPDR S&P Biotech ETF in the 1st quarter valued at $547,000. Keystone Investors PTE Ltd. acquired a new stake in SPDR S&P Biotech ETF in the 4th quarter valued at $12,022,000. Continuum Advisory LLC raised its position in SPDR S&P Biotech ETF by 389.1% in the second quarter. Continuum Advisory LLC now owns 18,013 shares of the exchange traded fund’s stock valued at $2,851,000 after purchasing an additional 14,330 shares during the period. Wellington Management Group LLP purchased a new position in SPDR S&P Biotech ETF in the second quarter valued at about $19,270,000. Finally, Jessup Wealth Management Inc acquired a new position in shares of SPDR S&P Biotech ETF during the fourth quarter worth about $1,053,000.

SPDR S&P Biotech ETF Price Performance

NYSEARCA XBI traded down $1.64 on Thursday, reaching $148.59. The company had a trading volume of 8,206,471 shares, compared to its average volume of 9,121,728. SPDR S&P Biotech ETF has a 1 year low of $103.43 and a 1 year high of $169.89. The firm has a 50-day moving average of $158.50 and a 200-day moving average of $145.70. The firm has a market capitalization of $9.71 billion, a PE ratio of 11.47 and a beta of 0.83.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.